These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 22115369)
1. Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. Archanioti P; Gazouli M; Theodoropoulos G; Vaiopoulou A; Nikiteas N J Crohns Colitis; 2011 Dec; 5(6):520-4. PubMed ID: 22115369 [TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect? de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020 [TBL] [Abstract][Full Text] [Related]
3. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease. Ghafouri-Fard S; Eghtedarian R; Taheri M Biomed Pharmacother; 2020 Sep; 129():110507. PubMed ID: 32768980 [TBL] [Abstract][Full Text] [Related]
4. IBD immunopathogenesis: A comprehensive review of inflammatory molecules. Park JH; Peyrin-Biroulet L; Eisenhut M; Shin JI Autoimmun Rev; 2017 Apr; 16(4):416-426. PubMed ID: 28212924 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer. Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337 [TBL] [Abstract][Full Text] [Related]
10. Salivary Stress/Immunological Markers in Crohn's Disease and Ulcerative Colitis. Finamore A; Peluso I; Cauli O Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202858 [TBL] [Abstract][Full Text] [Related]
11. Advances in understanding the role of cytokines in inflammatory bowel disease. Bevivino G; Monteleone G Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):907-915. PubMed ID: 30024302 [TBL] [Abstract][Full Text] [Related]
12. Trefoil factors in inflammatory bowel disease. Aamann L; Vestergaard EM; Grønbæk H World J Gastroenterol; 2014 Mar; 20(12):3223-30. PubMed ID: 24696606 [TBL] [Abstract][Full Text] [Related]
13. Candidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology. Florholmen J; Fries W Scand J Gastroenterol; 2011 Dec; 46(12):1407-17. PubMed ID: 22040230 [TBL] [Abstract][Full Text] [Related]
14. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Sartor RB Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232 [TBL] [Abstract][Full Text] [Related]
16. Abnormal mucosal immune response to altered bacterial flora following restorative proctocolectomy in patients with ulcerative colitis: serologic measures, immunogenetics, and clinical correlations. Sheikh S; Uno J; Matsuoka K; Plevy S Clin Immunol; 2008 Jun; 127(3):270-9. PubMed ID: 18499066 [TBL] [Abstract][Full Text] [Related]
17. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? Ansari N; Abdulla J; Zayyani N; Brahmi U; Taha S; Satir AA J Clin Pathol; 2006 Oct; 59(10):1066-72. PubMed ID: 16565224 [TBL] [Abstract][Full Text] [Related]
18. [Physiopathology of inflammatory bowel diseases]. Pariente EA Rev Prat; 1991 Feb; 41(5):397-401. PubMed ID: 2011686 [TBL] [Abstract][Full Text] [Related]